Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neos Therapeutics Inc. NEOS

Healthcare Drug Manufacturers - Major
Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The product portfolio of the company includes Methylphenidate XR-ODT and Amphetamine XR oral suspension commonly prescribed medicine for the treatment of ADHD. In... see more

Recent & Breaking News (NDAQ:NEOS)

Neos Therapeutics to Host Second Quarter 2019 Financial and Operating Results Conference Call on August 8th, 2019

GlobeNewswire August 1, 2019

Neos Therapeutics to Present at Two Upcoming June Conferences

GlobeNewswire June 12, 2019

Neos Therapeutics to Present at the Jefferies 2019 Global Healthcare Conference

GlobeNewswire May 30, 2019

Neos Therapeutics Reports First Quarter 2019 Financial Results

GlobeNewswire May 9, 2019

Neos Therapeutics to Host First Quarter 2019 Financial and Operating Results Conference Call on May 9th, 2019

GlobeNewswire May 2, 2019

Neos Therapeutics Announces Settlement with Teva on Cotempla XR-ODT® Patent Litigation

GlobeNewswire December 26, 2018

Neos Therapeutics Announces Realignment of Commercial Organization

GlobeNewswire November 30, 2018

Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer

GlobeNewswire November 27, 2018

Detailed Research: Economic Perspectives on Genocea Biosciences, Big Lots, SemGroup, Conn's, Mimecast, and Neos Therapeutics — What Drives Growth in Today's Competitive Landscape

GlobeNewswire November 27, 2018

Neos Therapeutics Reports Third Quarter 2018 Financial Results

GlobeNewswire November 9, 2018

Neos Therapeutics Announces Pricing of Underwritten Public Offering of $40 Million of Common Stock

GlobeNewswire November 6, 2018

Neos Therapeutics Announces Proposed Offering of Common Stock

GlobeNewswire November 5, 2018

Neos Therapeutics to Host Third Quarter 2018 Financial Results Conference Call on November 9, 2018

GlobeNewswire November 2, 2018

Neos Therapeutics to Present New Data for ADHD Medication, Adzenys XR-ODT®, at the American Academy of Child & Adolescent Psychiatry Meeting

GlobeNewswire October 24, 2018

Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea (Excessive Drooling)

GlobeNewswire October 23, 2018

New Research Coverage Highlights Amtech, Neos Therapeutics, FTD Companies, John B. Sanfilippo & Son, Molecular Templates, and Aevi Genomic Medicine — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire October 16, 2018

Neos Therapeutics to Present at the Cantor Global Healthcare Conference

GlobeNewswire September 26, 2018

Neos Therapeutics to Present at the Wells Fargo Healthcare Conference

GlobeNewswire August 29, 2018

Neos Therapeutics Reports Second Quarter 2018 Financial Results

GlobeNewswire August 8, 2018

Neos Therapeutics to Host Second Quarter 2018 Financial Results Conference Call on August 8, 2018

GlobeNewswire August 1, 2018